台股 » 個股 » 華上 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

華上

(6289)
  • 股價
    1.35
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    0
  • 產業
    上市 發光二極體(LED)
  • 27人加入追蹤

    立即追蹤

  • 本地時間:14:35

     
華上 (6289)籌碼相關-華南永昌-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2022/09/06201.2400.001.13202857.00%
2022/09/0100.0020.790.94-2206-0.97%
2022/08/3100.0019.80.750.86-19.8160-12.32%
2022/08/1701.9400.001.940710.00%
2022/08/1600.0012.152.15-167-1.49%
2022/07/2102.2500.002.320500.01%
2022/06/0922.9400.002.942613.25%
2022/05/0400.0002.642.700810.00%
2022/03/2203.2300.003.3402140.00%
2022/02/2503.3000.003.0502020.00%
2022/02/2303.3000.003.0302010.00%
2022/02/2203.1600.003.0002030.00%
2022/02/0903.2100.003.2501910.00%
2022/02/0803.3600.003.2201890.00%
2022/02/0703.1500.003.2001880.00%
2022/01/2403.0700.003.4601860.00%
2022/01/0600.0053.363.36-590-5.50%
2021/12/3042.4900.002.494606.56%
2021/12/2912.4900.002.511581.71%
2021/07/2200.0003.203.190690.00%
2021/07/2103.1400.003.190690.00%
2021/07/0700.0033.353.37-390-3.33%
2021/07/0213.0000.002.991881.13%
2021/07/0100.000.32.992.99-0.388-0.36%
2021/06/3000.0023.023.02-288-2.27%
2021/06/0900.0042.982.98-499-4.01%
2021/06/0842.7500.002.964994.01%
2021/05/2100.0063.233.23-6101-5.94%
2021/05/0413.3100.003.2511020.98%
2021/04/2823.7000.003.7021021.96%
2021/04/270.23.6000.003.650.21020.19%
2021/04/2313.7000.003.7911020.98%
2021/04/0600.0010.12.902.94-10.183-12.09%
2021/03/1900.0032.942.94-383-3.60%
2021/03/1832.8600.002.953833.61%
2021/02/230.23.1000.003.050.2860.19%
2020/12/1700.000.62.962.96-0.6206-0.29%
2020/10/1600.000.64.774.54-0.6342-0.18%
2020/09/22106.4500.006.47102623.80%
2020/05/2601.6700.001.870720.01%
2020/05/1100.000.71.731.76-0.7104-0.66%
2020/04/0701.6400.001.7001650.00%
2020/03/2000.00211.451.45-21227-9.25%
2020/03/1900.0091.451.41-9232-3.88%
2020/03/1102.0700.002.0702610.00%
2020/03/1002.3000.002.3002740.00%
2020/03/0902.5500.002.5502790.00%
2020/01/1600.7600.000.8402720.00%
2019/11/2700.0010.750.75-1164-0.61%
2019/11/2210.8600.000.8211450.69%
2019/03/2801.0100.001.0201370.00%
2019/03/0700.0011.071.06-1142-0.70%
2019/03/0600.0011.131.10-1139-0.72%
2019/03/0511.0000.001.0811380.72%
2019/02/2101.2300.001.2401190.00%
2019/01/1701.1200.001.120870.00%
2019/01/1101.0700.001.120890.00%
2018/12/2801.1600.001.200920.00%
2018/12/2700.0011.161.16-189-1.11%
2018/12/2000.00551.041.04-5587-62.91%
2018/11/1411.2700.001.2711330.75%
2018/11/0700.0011.251.25-1130-0.77%
2018/11/0111.2111.301.1801300.00%
2018/10/3111.2100.001.2011290.77%
2018/09/2500.0011.511.52-1216-0.46%
2018/09/14371.5700.001.563721617.12%
2018/09/1321.5600.001.5622140.93%
2018/09/12611.4311.451.516021228.26%
2018/09/1111.3600.001.4512080.48%
2018/07/3000.0001.941.8501840.00%
2018/07/2600.0011.821.61-1163-0.61%
2018/07/2400.0021.621.62-2130-1.53%
2018/07/1711.4600.001.4411090.92%
2018/07/1611.5100.001.5111040.95%
2018/06/2000.00331.661.70-33123-26.69%
2018/05/2100.00121.691.72-12111-10.79%
2018/04/2001.9600.001.9801140.01%
2018/03/3001.9700.002.070970.03%
乳癌新藥剋必達上市 華上生醫IPO時程加速Anue鉅亨-2023/09/12
〈華上生醫展望〉乳癌新成分新藥拓展新適應症 肝癌試驗拚年底完成Anue鉅亨-2023/09/08
華上 相關文章